9,466 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) …

Dec 2, 2024 · Fred Alger Management LLC acquired a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 9,466 …

7%
OFF

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Acquired By

2 weeks from now

Dec 10, 2024 · BNP Paribas Financial Markets raised its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 71.7% during the 3rd quarter, according …

marketbeat.com

9%
OFF

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought By

2 weeks from now

5 days ago · JPMorgan Chase & Co. lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 14.9% in the third quarter, according to its most recent …

marketbeat.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

15 hours ago · Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of …

yahoo.com

17%
OFF

Axsome (AXSM) Stock Up 17% In Six Months: Here's Why

2 weeks from now

Mar 20, 2023 · Jasper therapeutics’ loss per share estimates have narrowed from $1.42 to 61 cents for 2023 and from $1.6 to 59 cents for 2024, in the past 60 days. The stock has surged …

nasdaq.com

$210
OFF

Axsome Therapeutics Inc News (AXSM) - Investing.com

2 weeks from now

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Axsome Therapeutics (NASDAQ:AXSM) Inc on Thursday, setting a price target of $210, which is approximately …

investing.com

$125.00
OFF

Axsome Therapeutics (AXSM) Gets A Buy From TD Cowen

2 weeks from now

19 hours ago · In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target of $125.00. The …

businessinsider.com

$82.57
OFF

AXSM - Axsome Therapeutics, Inc. (NasdaqGM) - Share Price And …

2 weeks from now

The share price of Axsome Therapeutics, Inc. as of January 8, 2025 is $82.57 / share. ... Hindustan Unilever in talks to acquire skincare startup Minimalist for Rs 3,000 crore ($350 …

fintel.io

$89.27
OFF

Needham & Company LLC Reiterates “Buy” Rating For Axsome …

2 weeks from now

1 day ago · Shares of NASDAQ AXSM opened at $89.27 on Monday. The business has a fifty day simple moving average of $92.21 and a 200 day simple moving average of $89.22. The …

etfdailynews.com

0%
OFF

Loomis Sayles & Co. L P Acquires 29,497 Shares Of Axsome …

2 weeks from now

Nov 26, 2024 · Loomis Sayles & Co. L P grew its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 11.0% in the third quarter, according to the company in its …

marketbeat.com

$1.34
OFF

Axsome Therapeutics (AXSM) Stock Price, News & Analysis

2 weeks from now

2 days ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM) posted its earnings results on Tuesday, November, 12th. The company reported ($1.34) earnings per share for the quarter, …

marketbeat.com

$89.27
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected To …

2 weeks from now

1 day ago · Axsome Therapeutics stock opened at $89.27 on Monday. Axsome Therapeutics has a 12 month low of $64.11 and a 12 month high of $105.00. The business’s fifty day simple …

etfdailynews.com

$25
OFF

Axsome Therapeutics Provides Preliminary Fourth Quarter And Full …

2 weeks from now

2 days ago · Sunosi preliminary 4Q and full year 2024 net product revenue of $25.7 million and $93.8 million, respectively. NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) — Axsome …

financialpost.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last? - MSN

2 weeks from now

Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of shares changing …

msn.com

$1.34
OFF

Truist Financial Forecasts Strong Price Appreciation For Axsome ...

2 weeks from now

2 days ago · Axsome Therapeutics (NASDAQ:AXSM - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($1.34) earnings per …

marketbeat.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of shares changing …

nasdaq.com

$64.11
OFF

Axsome Therapeutics' (AXSM) "Buy" Rating Reaffirmed At …

2 weeks from now

1 day ago · Axsome Therapeutics has a 12 month low of $64.11 and a 12 month high of $105.00. The company has a quick ratio of 2.37, a current ratio of 2.44 and a debt-to-equity ratio of …

marketbeat.com

3%
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.3% On

2 weeks from now

2 days ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report)'s share price rose 5.3% during trading on Monday after Truist Financial raised their price target on the stock from …

marketbeat.com

FAQs about 9,466 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) … Coupon?

Where can I buy Axsome Therapeutics stock?

Shares of AXSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Axsome Therapeutics own? ...

How much did Axsome Therapeutics (axsm) raise?

Axsome Therapeutics (AXSM) raised $52 million in an initial public offering on Thursday, November 19th 2015. The company issued 4,300,000 shares at a price of $11.00-$13.00 per share. Ladenburg Thalmann and Cantor Fitzgerald & Co. served as the underwriters for the IPO and Brean Capital was co-manager. ...

Should you buy Axsome Therapeutics (axsm – research report)?

In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target of $125.00. The company’s shares closed yesterday at $89.27. According to TipRanks, Thome is an analyst with an average return of -5.0% and a 37.95% success rate. ...

Who is Axsome Therapeutics (axsm)?

Begin your TipRanks Premium journey today. Axsome Therapeutics (AXSM) Company Description: Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. ...

When is Axsome Therapeutics's next earnings report?

Axsome Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, August 7th, 2023. Axsome Therapeutics will be holding an earnings conference call on Monday, August 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. When is Axsome Therapeutics's earnings date? ...

How did Axsome Therapeutics (axsm) perform in the quarter?

Axsome Therapeutics, Inc. (NASDAQ:AXSM) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($1.34) EPS for the quarter, topping the consensus estimate of ($1.38) by $0.04. The company had revenue of $104.76 million for the quarter, compared to analyst estimates of $98.71 million. ...